Schonfeld Strategic Advisors LLC Puma Biotechnology, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$15.4 Billion
Q4 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 35,300 shares of PBYI stock, worth $103,076. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,300

Previous 117,900 70.06%

Holding current value

$103,076

Previous $300,000 64.33%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$2.42 - $3.39 $199,892 - $280,014	-82,600 Reduced 70.06%	35,300 $107,000
Q3 2024 Nov 14, 2024	SELL	$2.25 - $4.03 $486,465 - $871,314	-216,207 Reduced 64.71%	117,900 $300,000
Q2 2024 Aug 14, 2024	BUY	$2.92 - $5.83 $839,508 - $1.68 Million	287,503 Added 616.91%	334,107 $1.09 Million
Q1 2024 May 15, 2024	BUY	$4.29 - $7.4 $113,878 - $196,433	26,545 Added 132.33%	46,604 $247,000
Q4 2023 Feb 14, 2024	BUY	$2.23 - $4.49 $44,731 - $90,064	20,059 New	20,059 $86,000
Q2 2020 Aug 14, 2020	SELL	$7.01 - $13.24 $123,249 - $232,785	-17,582 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$6.28 - $14.57 $383,745 - $890,314	-61,106 Reduced 77.66%	17,582 $148,000
Q4 2019 Feb 14, 2020	BUY	$6.5 - $10.73 $511,472 - $844,322	78,688 New	78,688 $689,000
Q3 2019 Nov 14, 2019	SELL	$8.75 - $12.85 $124,250 - $182,470	-14,200 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$12.3 - $35.76 $51,660 - $150,192	4,200 Added 42.0%	14,200 $180,000
Q1 2019 May 15, 2019	SELL	$20.77 - $42.37 $636,683 - $1.3 Million	-30,654 Reduced 75.4%	10,000 $388,000
Q4 2018 Feb 14, 2019	BUY	$20.07 - $46.7 $709,554 - $1.65 Million	35,354 Added 667.06%	40,654 $827,000
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $74,160 - $107,730	1,800 Added 51.43%	5,300 $243,000
Q2 2018 Aug 14, 2018	BUY	$48.3 - $68.25 $169,050 - $238,875	3,500 New	3,500 $207,000
Q4 2017 Feb 14, 2018	SELL	$93.85 - $132.45 $1.54 Million - $2.17 Million	-16,365 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $1.18 Million - $1.96 Million	16,365	16,365 $1.96 Million

Others Institutions Holding PBYI

# of Institutions

110

Shares Held

28.3M

Call Options Held

27.9K

Put Options Held

3.4K

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $133M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Puma Biotechnology, Inc. Transaction History